Background: Local and systemic corticosteroids have long been the workhorse in management of chronic rhinosinusitis with nasal polyps (CRSwNP), although there is no universally accepted modality of prescription. We carried out a survey in Italy to capture current trends in the use of topical and systemic corticosteroids in patients with CRSwNP. Methods: A survey was set up on Survey Monkey^®. Each author distributed the link to the survey in an ad hoc manner and a total of 437 participants filled out the survey. Results: Mometasone furoate (79.3%) was the most frequently prescribed, administered daily by 61.9% of participants; the remaining preferred to discontinue treatment for brief periods to reduce side effects or to modulate the therapy in mild cases. The majority believe that a short cycle of systemic steroids should be prescribed for re-exacerbation of symptoms and that the number of cycles in the previous year should be evaluated to define control of the disease even if international guidelines do not provide clear indications on this topic. A certain degree of divergence emerged from responses regarding how long and the maximal dose of systemic steroids which place patients at high risk for adverse events. Finally, systemic corticosteroids seem to offer only temporary benefit on recovery of smell without guaranteeing long-term control even if the patient is adherent to topical corticosteroids. Conclusions: Our results highlight the need for clear guidelines on oral steroids, which could help supporting the use of a precision medicine approach, including indications for new biological agents.

To compare 3 different devices used to perforate the stapes footplate in otosclerotic patients. The study design was a prospective unblinded study. It was conducted at the ENT Department of a general hospital. Ninety subjects undergoing primary stapedotomy for otosclerosis by a senior surgeon participated. A stapedotomy operation was performed under local anesthesia with reversed sequence of surgical steps. Three different devices were used to perforate the posterior half of the footplate: a microdrill (MD), a CO2 laser (CO2), and a Piezosurgery bone device (PZS). The hole diameter was 0.7 mm. Three consecutive samples of unselected patients were recruited. All patients of each sample were operated with the same device. Main outcome measures were preoperative and postoperative air- (AC) and bone-conduction (BC) audiometry, intraoperative findings, and postoperative complications. Postoperative pure-tone audiometry was done 1 month after surgery. The CO2 laser was used in 30 stapedotomies, the PZS in 30, and the MD was used in 30. Bone-conduction pure-tone averages did not worsen in the MD and CO2 groups. CO2 laser shows a trend toward less residual air-bone gap and more functional gain at low frequencies. Piezosurgery bone device patients lost approximately 10 dB in BC at 4,000 Hz. Significant differences in AC thresholds gain and in the residual air-bone gap were found between groups. Piezosurgery bone device patients had less gain and more residual gap at high frequencies as a result of a slight deterioration of BC threshold. A higher rate of postoperative vertigo was also found in PZS patients. The use of the CO2 laser seems associated with the best functional results, although on a statistical basis, they do not differ significantly from that obtained with the standard MD platinotomy. The PZS stapedotomy is effective from a surgical point of view for most patients. However, it is associated with a slight but significant deterioration of BC at high frequency and at higher vertigo rate. More basic validation of the stimulation parameters is necessary for safe use of this new technology.

Objective: To evaluate the Piezosurgery (PZS) ultrasonic bone dissector as an alternative to conventional drilling to implant the Vibrant Soundbridge transducer in the round window (RW) niche. Study Design: Prospective noncontrolled study. Audiologic and surgical records analysis. Methods: Eight patients with mixed hearing loss and previous unsuccessful otologic surgeries were recruited. A transcanal or transmastoid approach was used. Round window osteoplasty was performed with the PZS device to implant the VBS floating mass transducer for cochlear stimulation. Results: The osteoplasty was performed safely with PZS, and all patients were successfully implanted. No sensorineural hearing deterioration occurred in all but 1 patient. The postoperative air conduction threshold was slightly higher than preoperatively because of minor middle ear transfer function changes. After fitting, patients continue to wear their speech processors full-time. The aided speech discrimination scores at conversational level ranged from 65 to 100%. Aided hearing threshold was 32.2 dB HL (preoperative threshold under earphones, 62.8 dB HL). One patient affected by congenital aural atresia had a posterior canalithiosis on the operated side that was successfully treated by the repositioning maneuver. Conclusion: The PZS device proved to be effective for RW osteoplasty; floating mass transducer was successfully implanted in all patients. Audiologic results are comparable to those obtained from traditionally operated patients. Relative to conventional drilling, the PZS allows a safer osteoplasty because it does not produce any rotation or torque that reduces the risk of RW membrane injury. Although hearing was preserved in our sample, the potential inner ear risks need to be further evaluated in both experimental and clinical fields.